Steve kelsey

Steve kelsey

Company: Revolution Medicines

Job title: President


Targeting RAS(ON) Beyond KRAS G12C 9:30 am

Targeting RAS(ON) v first generation RAS(OFF) inhibitors Drugging RAS beyond G12C Targeted and rational combinationsRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.